{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T23:53:42Z","timestamp":1789862022494,"version":"4.0.1"},"reference-count":19,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1016\/j.biopha.2009.09.012","type":"journal-article","created":{"date-parts":[[2009,11,6]],"date-time":"2009-11-06T04:12:36Z","timestamp":1257480756000},"page":"160-164","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["ADAMTS4 level in patients with stable coronary artery disease and acute coronary syndromes"],"prefix":"10.1016","volume":"64","author":[{"given":"Yanping","family":"Zha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fayun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanyan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianqun","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2009.09.012_bib1","doi-asserted-by":"crossref","unstructured":"Tang, BT. ADAMTS: a novel family of extracellular matrix proteases. Int J Biochem Cell Biol 2001;3:33\u201344.","DOI":"10.1016\/S1357-2725(00)00061-3"},{"key":"10.1016\/j.biopha.2009.09.012_bib2","doi-asserted-by":"crossref","unstructured":"W\u00e5gs\u00e4ter D, Bj\u00f6rk H, Zhu C, Bj\u00f6rkegren J, Valen G, Hamsten A et al. ADAMTS-4 and -8 are inflammatory regulated enzymes expressed in macrophage-rich areas of human atherosclerotic plaques. Atherosclerosis 2008;196:514\u201322.","DOI":"10.1016\/j.atherosclerosis.2007.05.018"},{"key":"10.1016\/j.biopha.2009.09.012_bib3","doi-asserted-by":"crossref","first-page":"13372","DOI":"10.1074\/jbc.M009737200","article-title":"Versican V1 proteolysis in human aorta in vivo occurs at the Glu441-Ala442 bond, a site that is cleaved by recombinant ADAMTS-1 and ADAMTS-4","volume":"276","author":"SandyF J.D.","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.biopha.2009.09.012_bib4","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1161\/res.90.3.251","article-title":"Matrix metalloproteinases in vascular remodeling and atherogenesis the good, the bad, and the ugly","volume":"90","author":"Galis","year":"2002","journal-title":"Circ Res"},{"key":"10.1016\/j.biopha.2009.09.012_bib5","doi-asserted-by":"crossref","unstructured":"Halpert I, Sires UI, Roby JD, Potter-Perigo S, Wight TN, Steven D et al. Matrilysin is expressed by lipid-laden macrophages at sites of potential rupture in atherosclerotic lesions and localizes to areas of versican deposition, a proteoglycan substrate for the enzyme (metalloelastase\/metalloproteinase\/chondroitin sulfate). Proc Natl Acad Sci U S A 1996;93:9748\u201353.","DOI":"10.1073\/pnas.93.18.9748"},{"key":"10.1016\/j.biopha.2009.09.012_bib6","doi-asserted-by":"crossref","first-page":"51340","DOI":"10.1074\/jbc.M310865200","article-title":"Metalloproteinase expression in PMA-stimulated THP-1","volume":"278","author":"Joanna","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.biopha.2009.09.012_bib7","doi-asserted-by":"crossref","first-page":"7345","DOI":"10.1074\/jbc.273.13.7345","article-title":"Specific interaction of the recombinant disintegrin-like domain of MDC-15 (metargidin, ADAM-15) with integrin alphavbeta3","volume":"273","author":"Zhang","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.biopha.2009.09.012_bib8","doi-asserted-by":"crossref","unstructured":"Eto K, Huet C, Tarui T, Kupriyanov S, Liu HZ, Puzon-McLaug W et al. Functional classification of ADAMs based on a conserved motif for binding to integrin alpha 9beta 1: implications for sperm-egg binding and other cell interactions. J Biol Chem 2002;277:17804\u201310.","DOI":"10.1074\/jbc.M200086200"},{"key":"10.1016\/j.biopha.2009.09.012_bib9","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.pharmthera.2006.02.009","article-title":"Breaking up the tie: disintegrin-like metalloproteinases as regulators of cell migration in inflammation and invasion","volume":"111","author":"Reiss","year":"2006","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.biopha.2009.09.012_bib10","doi-asserted-by":"crossref","first-page":"19349","DOI":"10.1016\/S0021-9258(18)41781-4","article-title":"Heparin-binding peptides from the type-I repeats of thrombospondin structural requirements for heparin-binding and promotion of melanoma cell-adhesion and chemotaxis","volume":"267","author":"Guo","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1016\/j.biopha.2009.09.012_bib11","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.1073\/pnas.89.7.3040","article-title":"Heparin-binding and sulfatide-binding peptides from the type-I repeats of human thrombospondin promote melanoma cell adhesion","volume":"89","author":"Guo","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopha.2009.09.012_bib12","doi-asserted-by":"crossref","unstructured":"Tortorella M, Pratta M, Liu RQ, Abbaszade I, Ross H, Bur T, et al. The thrombospondin motif of aggrecanase -1 (ADAMTS-4) is critical for aggrecan substrate recognition and cleavage. J Biol Chem 2000;275:25791\u20137.","DOI":"10.1074\/jbc.M001065200"},{"key":"10.1016\/j.biopha.2009.09.012_bib13","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach","volume":"44","author":"DeLong","year":"1988","journal-title":"Biometrics"},{"key":"10.1016\/j.biopha.2009.09.012_bib14","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/00045415-200008010-00007","article-title":"Plaque disruption and thrombosis: potential role of inflammation and infection","volume":"8","author":"Shah","year":"2000","journal-title":"Cardiol Rev"},{"issue":"Suppl. 1","key":"10.1016\/j.biopha.2009.09.012_bib15","first-page":"1","article-title":"Plaque rupture and plaque erosion","volume":"82","author":"Virmani","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.biopha.2009.09.012_bib16","first-page":"33","article-title":"Lipid and cellular constituents of unstable human aortic plaques","volume":"89","author":"Davies","year":"1994","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.biopha.2009.09.012_bib17","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.tcm.2006.03.011","article-title":"Versican degradation and vascular disease","volume":"16","author":"Kenagy","year":"2006","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.biopha.2009.09.012_bib18","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1161\/01.CIR.92.3.657","article-title":"Coronary plaque disruption","volume":"92","author":"Falk","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2009.09.012_bib19","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1161\/01.CIR.99.3.361","article-title":"Association between myocardial infarction and the mast cells in the adventitia of the infarct-related coronary artery","volume":"99","author":"Laine","year":"1999","journal-title":"Circulation"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332209002017?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332209002017?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T10:44:17Z","timestamp":1760093057000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332209002017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["S0753332209002017"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2009.09.012","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ADAMTS4 level in patients with stable coronary artery disease and acute coronary syndromes","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2009.09.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}